Delays are not uncommon.
I’ve been waiting since 2016 for a pivotal results trial to be forfilled. An extra month or so is not an issue.
A well run site that sticks to protocols is the key and the data collation is solid. I think we are in safe hands.
In the last year before pivotal results, I feel that it’s at the ‘top of the straight’ to the commercial finish line.
And @vintage, I couldn’t agree with you more
cheers
Ann: Dimerix presentation at Bioshares Biotech Summit, page-52
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
50.0¢ |
Change
-0.010(1.96%) |
Mkt cap ! $280.6M | |||
| Open | High | Low | Value | Volume |
| 51.0¢ | 51.5¢ | 49.8¢ | $224.7K | 444.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 66886 | 49.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 52730 | 5 |
View Market Depth
| Last trade - 10.12am 17/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |